Design of nonhypertensive conjugated hemoglobins as novel resuscitation fluids

Seetharama A. Acharya, Marcos Intaglietta, Amy G. Tsai, Fantao Meng

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Enhancing the molecular size/volume Hb was introduced, as a simple molecular approach to overcome or attenuate the extravasation mediated NO scavenging activity of Hb in vivo. Conjugation of Hb, as a chemical tool to achieve this objective, has now advanced beyond this initial concept. It requires us now to recognize that engineering of resuscitation fluids like properties to Hb is a novel concept and simple approach to neutralize/attenuate the in vivo hypertensive activity of acellular Hb. Development of conjugated hemoglobins is reviewed here as it lead to the development of this concept along with future perspectives. Extension Arm chemistry, that integrates the concepts of click chemistry into the various conjugation approaches of relevance to this aspect of blood substitute research is discussed. Bridging these approaches to increase the efficacy of engineering resuscitation fluid like properties to Hb is suggested as the future direction of designing conjugated Hbs as oxygen therapeutics. The integration of site directed mutagenesis to tame the molecular properties of Hb with the extension arm facilitated PEGylation to attenuate the impact of conjugation chemistry and/or conjugated polymer on the tertiary/quaternary structure of the Hb molecule is discussed in detail as applied to PEGylation of Hb as the conjugation approach of choice to generate nonhypertensive Hb as oxygen therapeutics. We conclude that such a synergistic approach will result in the attenuation of heme degradation product dependent and oxidative stress mediated in vivo toxicity as well as facilitating an increase in the oxygen delivering capacity of the conjugated Hb.

Original languageEnglish (US)
Title of host publicationHemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics
PublisherSpringer-Verlag Berlin Heidelberg
Pages185-234
Number of pages50
ISBN (Print)9783642407178, 3642407161, 9783642407161
DOIs
StatePublished - Oct 1 2014

Fingerprint

Resuscitation
Hemoglobin
Hemoglobins
Oxygen
Fluids
Blood substitutes
Click Chemistry
Blood Substitutes
Mutagenesis
Oxidative stress
Conjugated polymers
Scavenging
Site-Directed Mutagenesis
Heme
Toxicity
Polymers
Oxidative Stress
Degradation
Molecules
Therapeutics

ASJC Scopus subject areas

  • Engineering(all)
  • Materials Science(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Acharya, S. A., Intaglietta, M., Tsai, A. G., & Meng, F. (2014). Design of nonhypertensive conjugated hemoglobins as novel resuscitation fluids. In Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics (pp. 185-234). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-40717-8_11

Design of nonhypertensive conjugated hemoglobins as novel resuscitation fluids. / Acharya, Seetharama A.; Intaglietta, Marcos; Tsai, Amy G.; Meng, Fantao.

Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Springer-Verlag Berlin Heidelberg, 2014. p. 185-234.

Research output: Chapter in Book/Report/Conference proceedingChapter

Acharya, SA, Intaglietta, M, Tsai, AG & Meng, F 2014, Design of nonhypertensive conjugated hemoglobins as novel resuscitation fluids. in Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Springer-Verlag Berlin Heidelberg, pp. 185-234. https://doi.org/10.1007/978-3-642-40717-8_11
Acharya SA, Intaglietta M, Tsai AG, Meng F. Design of nonhypertensive conjugated hemoglobins as novel resuscitation fluids. In Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Springer-Verlag Berlin Heidelberg. 2014. p. 185-234 https://doi.org/10.1007/978-3-642-40717-8_11
Acharya, Seetharama A. ; Intaglietta, Marcos ; Tsai, Amy G. ; Meng, Fantao. / Design of nonhypertensive conjugated hemoglobins as novel resuscitation fluids. Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Springer-Verlag Berlin Heidelberg, 2014. pp. 185-234
@inbook{36ce635a65af4abf8a789de45e32a036,
title = "Design of nonhypertensive conjugated hemoglobins as novel resuscitation fluids",
abstract = "Enhancing the molecular size/volume Hb was introduced, as a simple molecular approach to overcome or attenuate the extravasation mediated NO scavenging activity of Hb in vivo. Conjugation of Hb, as a chemical tool to achieve this objective, has now advanced beyond this initial concept. It requires us now to recognize that engineering of resuscitation fluids like properties to Hb is a novel concept and simple approach to neutralize/attenuate the in vivo hypertensive activity of acellular Hb. Development of conjugated hemoglobins is reviewed here as it lead to the development of this concept along with future perspectives. Extension Arm chemistry, that integrates the concepts of click chemistry into the various conjugation approaches of relevance to this aspect of blood substitute research is discussed. Bridging these approaches to increase the efficacy of engineering resuscitation fluid like properties to Hb is suggested as the future direction of designing conjugated Hbs as oxygen therapeutics. The integration of site directed mutagenesis to tame the molecular properties of Hb with the extension arm facilitated PEGylation to attenuate the impact of conjugation chemistry and/or conjugated polymer on the tertiary/quaternary structure of the Hb molecule is discussed in detail as applied to PEGylation of Hb as the conjugation approach of choice to generate nonhypertensive Hb as oxygen therapeutics. We conclude that such a synergistic approach will result in the attenuation of heme degradation product dependent and oxidative stress mediated in vivo toxicity as well as facilitating an increase in the oxygen delivering capacity of the conjugated Hb.",
author = "Acharya, {Seetharama A.} and Marcos Intaglietta and Tsai, {Amy G.} and Fantao Meng",
year = "2014",
month = "10",
day = "1",
doi = "10.1007/978-3-642-40717-8_11",
language = "English (US)",
isbn = "9783642407178",
pages = "185--234",
booktitle = "Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics",
publisher = "Springer-Verlag Berlin Heidelberg",

}

TY - CHAP

T1 - Design of nonhypertensive conjugated hemoglobins as novel resuscitation fluids

AU - Acharya, Seetharama A.

AU - Intaglietta, Marcos

AU - Tsai, Amy G.

AU - Meng, Fantao

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Enhancing the molecular size/volume Hb was introduced, as a simple molecular approach to overcome or attenuate the extravasation mediated NO scavenging activity of Hb in vivo. Conjugation of Hb, as a chemical tool to achieve this objective, has now advanced beyond this initial concept. It requires us now to recognize that engineering of resuscitation fluids like properties to Hb is a novel concept and simple approach to neutralize/attenuate the in vivo hypertensive activity of acellular Hb. Development of conjugated hemoglobins is reviewed here as it lead to the development of this concept along with future perspectives. Extension Arm chemistry, that integrates the concepts of click chemistry into the various conjugation approaches of relevance to this aspect of blood substitute research is discussed. Bridging these approaches to increase the efficacy of engineering resuscitation fluid like properties to Hb is suggested as the future direction of designing conjugated Hbs as oxygen therapeutics. The integration of site directed mutagenesis to tame the molecular properties of Hb with the extension arm facilitated PEGylation to attenuate the impact of conjugation chemistry and/or conjugated polymer on the tertiary/quaternary structure of the Hb molecule is discussed in detail as applied to PEGylation of Hb as the conjugation approach of choice to generate nonhypertensive Hb as oxygen therapeutics. We conclude that such a synergistic approach will result in the attenuation of heme degradation product dependent and oxidative stress mediated in vivo toxicity as well as facilitating an increase in the oxygen delivering capacity of the conjugated Hb.

AB - Enhancing the molecular size/volume Hb was introduced, as a simple molecular approach to overcome or attenuate the extravasation mediated NO scavenging activity of Hb in vivo. Conjugation of Hb, as a chemical tool to achieve this objective, has now advanced beyond this initial concept. It requires us now to recognize that engineering of resuscitation fluids like properties to Hb is a novel concept and simple approach to neutralize/attenuate the in vivo hypertensive activity of acellular Hb. Development of conjugated hemoglobins is reviewed here as it lead to the development of this concept along with future perspectives. Extension Arm chemistry, that integrates the concepts of click chemistry into the various conjugation approaches of relevance to this aspect of blood substitute research is discussed. Bridging these approaches to increase the efficacy of engineering resuscitation fluid like properties to Hb is suggested as the future direction of designing conjugated Hbs as oxygen therapeutics. The integration of site directed mutagenesis to tame the molecular properties of Hb with the extension arm facilitated PEGylation to attenuate the impact of conjugation chemistry and/or conjugated polymer on the tertiary/quaternary structure of the Hb molecule is discussed in detail as applied to PEGylation of Hb as the conjugation approach of choice to generate nonhypertensive Hb as oxygen therapeutics. We conclude that such a synergistic approach will result in the attenuation of heme degradation product dependent and oxidative stress mediated in vivo toxicity as well as facilitating an increase in the oxygen delivering capacity of the conjugated Hb.

UR - http://www.scopus.com/inward/record.url?scp=84930350320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930350320&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-40717-8_11

DO - 10.1007/978-3-642-40717-8_11

M3 - Chapter

AN - SCOPUS:84930350320

SN - 9783642407178

SN - 3642407161

SN - 9783642407161

SP - 185

EP - 234

BT - Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

PB - Springer-Verlag Berlin Heidelberg

ER -